Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-06 · accession 0001415889-24-028692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $4.67 | +25.7K | 3.43M | +0.8% | +$119.9K |
| DI | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $8.42 | +11.9K | 4.33M | +0.3% | +$100.0K |
| DI | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $0.00 | -11.9K | 1.09M | -1% | $0 |
| DM | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $0.00 | -25.7K | 20.7K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-06 | M | A | 13,789 | $1.44 | 3,421,636 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-06 | M | A | 11,876 | $8.42 | 4,327,189 | I By Spouse | — | — | |
| 3 | Common | Common Stock | 2024-12-06 | M | A | 11,876 | $8.42 | 3,433,512 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-12-06 | M | D | 11,876 | $0.00 | 1,088,124 | I By Spouse | $8.42 · — to 2033-01-02 | 11,876 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |
| 5 | Derivative | Stock Option (right to buy) | 2024-12-06 | M | D | 11,876 | $0.00 | 338,124 | D | $8.42 · — to 2033-01-02 | 11,876 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |
| 6 | Derivative | Stock Option (right to buy) | 2024-12-06 | M | D | 13,789 | $0.00 | 20,684 | D | $1.44 · — to 2031-12-13 | 13,789 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |